First-in-human study of the safety, pharmacokinetics, and

Justifying Ribociclib Dose in Patients with Advanced Breast Cancer

Find a clinical trial

Preclinical characterization of the Toll-like receptor 7/8 antagonist MHV370 for lupus therapy - ScienceDirect

Dose Proportionality In Drug Development -BioPharma Services

Clinical Trial Phases, PDF

IJMS, Free Full-Text

Lipogenesis inhibitors: therapeutic opportunities and challenges

Cells, Free Full-Text

First-in-human study of the safety, pharmacokinetics, and